NTRK1 and Alzheimer disease: The largely documented role of NGF-TrkA complex in this scenario, summarized in this review and in other studies, points to NGF as an actually potent therapeutic agent in AD and has implications for the pathological effect of its reduced supply to basal forebrain cholinergic neurons.